Which Criteria are More Valuable in Defining Hemodynamic Significance of Patent Ductus Arteriosus in Premature Infants? Respiratory or Echocardiographic?

ŞAHİN, Irfan; YOLCU, Canan; ŞAHİN, Aysegul; KARA, Mustafa; Demirelli, Yaşar; Olgun, Haşim; CEVİZ, Naci

doi:10.4274/haseki.3278

Which Criteria are More Valuable in Defining Hemodynamic Significance of Patent Ductus Arteriosus in Premature Infants? Respiratory or Echocardiographic?

ŞAHİN I. O., YOLCU C., ŞAHİN A. E., KARA M., Demirelli Y., Olgun H., ...Daha Fazla

HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, cilt.55, sa.1, ss.32-36, 2017 (ESCI)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 55 Sayı: 1
Basım Tarihi: 2017
Doi Numarası: 10.4274/haseki.3278
Dergi Adı: HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.32-36
Atatürk Üniversitesi Adresli: Evet

Özet

Aim: Patent ductus arteriosus (PDA) is a frequent health problem in premature infants. Pharmacologic closure is recommended only for hemodynamically significant PDA (hsPDA) that is defined according to the clinical and echocardiographic criteria. The aim of this study was to explore the value of commonly used criteria in defining hsPDA and predicting the required number of courses of ibuprofen treatment to close PDA in premature infants.